Syrup of ipecac is a plant-derived liquid that triggers forceful vomiting within about fifteen minutes of swallowing it. For decades it sat in family medicine cabinets across the United States, endorsed by pediatricians as a first-line home treatment when a child swallowed something poisonous. That recommendation was reversed in 2003, and today no major medical organization advises keeping ipecac in the home. The reversal came down to a straightforward problem: despite reliably making people throw up, ipecac never showed convincing evidence of actually improving outcomes for poisoned patients, and its risks turned out to be more serious than anyone initially appreciated.
Where Ipecac Came From
The plant behind ipecac, a small shrub in the genus Cephaelis, is native to the rainforests of Brazil. Europeans first encountered it in the 1600s, and it was transported to Paris later that century. A physician named Helvetius used it on members of the French royal court to treat dysentery, with apparent success.1PubMed. Ipecacuanha: the South American vomiting root The plant’s active compounds, primarily emetine and cephaeline, irritate the stomach lining and stimulate a vomiting center in the brain. That dual action made it a potent emetic, and by the twentieth century, a concentrated syrup preparation was being manufactured specifically for poisoning emergencies.
By the mid-twentieth century, syrup of ipecac had become a fixture of American pediatric safety. The American Academy of Pediatrics (AAP) actively supported keeping it in homes with young children, and poison control centers routinely advised parents to administer it after accidental ingestions. The logic seemed sound: a toddler swallows something dangerous, you give ipecac, the child vomits it back up before too much is absorbed. In practice, though, this logic rested on assumptions that had never been tested rigorously.
The Evidence That Turned the Tide
When researchers finally scrutinized ipecac’s track record, the results were disappointing. A major clinical guideline published in 2005 concluded that ipecac’s ability to improve patient outcomes had never been demonstrated in adequate clinical trials. Its ability to prevent drug absorption had only been documented for a limited number of substances, and that ability dropped substantially if the syrup was given more than thirty to ninety minutes after someone swallowed the poison.2PubMed. Guideline on the use of ipecac syrup in the out-of-hospital management of ingested poisons A follow-up review in 2013 echoed those conclusions, finding no convincing evidence from clinical studies that ipecac improved the outcome of poisoned patients.3PubMed. Position paper update: ipecac syrup for gastrointestinal decontamination
An earlier position paper had already reached the same verdict: in experimental studies, the amount of ingested substance removed by ipecac-induced vomiting was highly variable and declined with time. The authors recommended that routine administration in the emergency department should be abandoned.4PubMed. Position paper: Ipecac syrup The variability was a critical problem. Vomiting might bring back a substantial amount of the swallowed substance in one case and almost nothing in another, with no reliable way to predict which scenario a given patient would fall into. And the clock was always working against the treatment: by the time a parent found the empty bottle, called for advice, located the ipecac, and waited the fifteen or so minutes for vomiting to begin, the window of meaningful benefit was often already closed.
Why Activated Charcoal Replaced It
The decline of ipecac coincided with growing confidence in a different approach: activated charcoal. Charcoal works through a completely different mechanism. Instead of trying to expel a poison, it binds to toxic molecules in the gut and prevents them from crossing into the bloodstream. A comparison study found that activated charcoal was significantly more effective than ipecac at reducing drug absorption when both were given at the same time points after ingestion.5PubMed Central. Comparison of activated charcoal and ipecac syrup in prevention of drug absorption Charcoal also has a wider window of usefulness: guidelines recommend administering it within the first hour after ingestion, and for certain slow-release medications, it can still help up to six hours later.6PubMed Central. The Use of Activated Charcoal to Treat Intoxications
Activated charcoal is not a universal fix. It does not work against poisoning from acids, bases, alcohols, organic solvents, or metals.6PubMed Central. The Use of Activated Charcoal to Treat Intoxications And it carries its own risk: if someone is drowsy or losing consciousness, they can aspirate the charcoal slurry into their lungs, which is dangerous. For that reason, its use generally requires clinical judgment, and in many cases it is given at a hospital rather than at home. But it still represents a clear upgrade over ipecac for the simple reason that it addresses the core problem, absorbing poison from the gut, without the drawbacks of forced vomiting.
Ipecac also created a practical conflict with charcoal. If you gave ipecac first and the patient spent twenty minutes vomiting, you then had to wait before giving charcoal, because the patient would likely throw it back up. That delay could matter. The comparison study found that even ipecac’s emetic action, despite being dramatic and thorough, was not very effective at preventing drug absorption. The researchers concluded that charcoal should be given after induced vomiting or gastric lavage regardless, which raised an obvious question: if charcoal is the real treatment, why bother with ipecac at all?5PubMed Central. Comparison of activated charcoal and ipecac syrup in prevention of drug absorption
Cardiac Dangers of Emetine
Beyond questions of efficacy, ipecac carried real risks. The compound emetine, one of the two main alkaloids in the syrup, is directly toxic to heart muscle. Laboratory research showed that emetine reduces the force of heart contractions and disrupts the normal electrical activity of the heart’s pacemaker nodes. This happens because emetine blocks a specific type of calcium channel in cardiac cells, the L-type channel, which the heart depends on to maintain its rhythm and pumping strength.7PubMed Central. Cardiotoxicity of emetine dihydrochloride by calcium channel blockade in isolated preparations and ventricular myocytes of guinea-pig hearts
For a single dose given once during an acute poisoning, this cardiac effect was unlikely to cause harm in most people. The danger escalated dramatically with repeated use. Emetine accumulates in muscle tissue, including the heart, and clears from the body slowly. Anyone using ipecac repeatedly was dosing themselves with a cardiotoxin that built up over time.
Ipecac Abuse in Eating Disorders
The cardiac toxicity of emetine turned from a theoretical concern into a well-documented clinical problem because of one population: people with eating disorders who used ipecac to purge. Ipecac was sold over the counter for decades, and individuals with bulimia or anorexia discovered that it was a reliable way to induce vomiting after eating. What they may not have known was that each dose was depositing emetine in their heart muscle.
Ipecac abuse occurred predominantly among adolescent and young adult women who were either experimenting with purging or had a diagnosed eating disorder. Psychiatric comorbidity was common. Deaths from ipecac abuse were usually cardiac in origin, and the range of damage was broad: myocarditis with arrhythmias, skeletal muscle inflammation, tears in the esophagus and stomach lining, chronic diarrhea, and metabolic disturbances including dangerously low potassium levels and dehydration.8Journal of Adolescent Health. Ipecac syrup abuse, morbidity, and mortality: Isn’t it time to repeal its over-the-counter status? Case reports documented patients with eating disorders who developed characteristic heart failure from chronic ipecac use, and the damage was sometimes reversible only if the person stopped taking it in time.9PubMed Central. Rapidly reversible cardiomyopathy associated with chronic ipecac ingestion
Ipecac was also flagged as a contributing factor in broader reviews of heart failure among anorexia patients, alongside malnutrition and deficiencies in thiamine, phosphorus, magnesium, and selenium.10PubMed. Heart failure in anorexia nervosa: case report and review of the literature The pattern of abuse gave the medical community one more powerful argument against keeping ipecac readily available. Easy over-the-counter access was fueling a form of self-harm that could be lethal.
The 2003 Policy Reversal
All of these strands converged in 2003, when the AAP officially reversed its longstanding recommendation and advised that ipecac should no longer be used for the home management of poisoning.11PubMed Central. Effects on a Poison Center’s (PC) triage and follow-up after implementing the no Ipecac use policy. The statement pointed to mounting evidence that ipecac use did not improve outcomes and did not reduce emergency department referrals. In other words, giving ipecac at home was neither making children better nor keeping them out of the hospital.
The fallout was rapid. Poison centers stopped recommending it. Pharmacies gradually pulled it from shelves or moved it behind the counter. Manufacturers eventually discontinued production of the syrup for consumer sale. By the 2010s, finding a bottle of ipecac in a drugstore was nearly impossible. Toxicology guidelines from multiple international bodies echoed the AAP’s position, and the consensus became remarkably unified: there was essentially no clinical scenario in the out-of-hospital setting where ipecac was the right choice.
After poison centers implemented the no-ipecac policy, a study evaluating the shift’s impact found that the change did not lead to a surge of worse outcomes. Calls were still triaged effectively, and the absence of ipecac from the home treatment toolkit did not create a gap in care.11PubMed Central. Effects on a Poison Center’s (PC) triage and follow-up after implementing the no Ipecac use policy. That confirmed what the evidence had been suggesting all along: the perceived safety net of having ipecac in the house was more psychological than medical.
Why Inducing Vomiting at Home Is Generally a Bad Idea
The demise of ipecac left some parents wondering what they should use instead. The answer, which can feel unsatisfying in a panicked moment, is: nothing you have in your kitchen. The instinct to make someone vomit after they swallow something toxic is deeply intuitive but medically problematic for several reasons. With certain substances, vomiting causes more damage on the way back up. Corrosive chemicals like drain cleaner burn the esophagus and throat a second time. Petroleum-based products like lamp oil carry a high risk of being inhaled into the lungs during vomiting, causing a chemical pneumonia that can be worse than the original poisoning.
The dangers of improvised home emetics go beyond these substance-specific risks. A case report described an adolescent whose parents gave him saltwater to induce vomiting after he reported possibly taking pills at a party. He vomited multiple times, then seized. His sodium levels rose to a critically dangerous level, and he died from brain swelling caused by the severe hypernatremia.12PubMed. Fatal hypernatremia from saltwater used as an emetic The authors published the case specifically to warn physicians and the public about the dangers of this “obsolete therapy.” Mustard water, another folk emetic, carries similar risks of its own and has no evidence supporting its use.
What to Do Instead
The current standard advice for a suspected poisoning at home is simple: call your regional poison control center. In the United States, the number is 1-800-222-1222 and connects to a center staffed by specially trained nurses and pharmacists around the clock. A study surveying primary care offices found that without a poison center available, over eighty percent of poisoning-related calls to doctors’ offices would result in a referral to 911 or an emergency department, many of which would be unnecessary. Poison centers play a critical role in triaging calls and preventing overuse of emergency services.13PubMed Central. A Survey of Primary Care Offices: Triage of Poisoning Calls without a Poison Control Center.
The poison center specialist will ask what was swallowed, how much, and how long ago, then advise whether the situation requires a trip to the emergency room or can be monitored at home. Most childhood ingestions, it turns out, involve substances or amounts that are not actually dangerous, and a poison center call can save the family an unnecessary and stressful ER visit. When the ingestion is serious and the patient reaches the hospital, the treatment team has several tools available depending on the substance. Activated charcoal remains a common option when it matches the situation. For certain specific poisonings, antidotes exist, including ones for acetaminophen, opioids, and some types of cardiac medications. In severe cases, more intensive measures like whole bowel irrigation or dialysis may be used.
Old Bottles Still in Medicine Cabinets
One lingering concern is that bottles of ipecac purchased years ago still sit in medicine cabinets in some homes. These bottles are expired, but the syrup does not simply become inert over time. The AAP and poison control centers have advised families to dispose of any remaining ipecac rather than keeping it “just in case.” The worry is not just that someone might use an expired product; it is that the product’s very presence encourages the wrong response during a crisis. A parent who finds ipecac in the cabinet during a moment of panic may administer it before calling for advice, losing precious time and potentially causing harm.
A study from the era when ipecac was still recommended found that a small but real fraction of parents were already using it without calling a poison center first. Among hospital patients, about six percent of parents who gave ipecac did so without any medical consultation. The vast majority happened to use it appropriately, but four percent gave it for a type of poisoning where it was contraindicated, meaning it could have made things worse.14PubMed Central. Risk assessment of ipecac in the home That error rate was small in percentage terms but represented real children put at unnecessary risk, and it bolstered the argument that having ipecac available at home was inviting unsupervised use.
Ipecac in Veterinary Practice
One place where induced vomiting still plays a routine role is veterinary medicine. When a dog eats something toxic, veterinarians frequently induce vomiting because the risk-benefit calculation is different than in humans. Dogs are less likely to aspirate vomit, and many common dog poisonings involve substances like chocolate or xylitol where removing the material quickly makes a clear difference. However, even in veterinary settings, ipecac has largely fallen out of favor. Hydrogen peroxide is the more common home emetic for dogs, and veterinary clinics typically use injectable medications that produce faster, more controlled vomiting. The shift away from ipecac in veterinary practice mirrors the human medical story: better alternatives exist, and ipecac’s side effects, including prolonged vomiting and the cardiac risks of emetine, make it a poor choice even for animals.
Cats are a different matter entirely. Ipecac is considered toxic to cats and should never be given to them. Even hydrogen peroxide is controversial in feline patients. For cat owners who suspect poisoning, the advice is the same as for parents of children: call a poison control line first, in this case the ASPCA Animal Poison Control Center or a veterinary emergency hospital, and let a professional decide on the next step.